Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?

Oncologist. 2004;9(5):594-5; author reply 596. doi: 10.1634/theoncologist.9-5-594.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use*
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / therapeutic use
  • Catheterization, Central Venous / adverse effects*
  • Catheters, Indwelling / adverse effects*
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Fluorouracil / adverse effects*
  • Fluorouracil / therapeutic use
  • Humans
  • International Normalized Ratio
  • Neoplasms / complications
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / adverse effects
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Warfarin / administration & dosage
  • Warfarin / adverse effects*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Antimetabolites, Antineoplastic
  • Organoplatinum Compounds
  • Oxaliplatin
  • Warfarin
  • Fluorouracil